Neoplasms, Colorectal Terminated Phase 2 Trials for Irinotecan (DB00762)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

DBCOND0036298 (Neoplasms, Colorectal)Terminated2 IdentifierTitlePurposeDrugs
NCT02842580De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal CancerTreatment
NCT00314353Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the ColonTreatment
NCT00040391A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal CancerTreatment
NCT00037180For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With ChemotherapyTreatment
NCT00106054Neoadjuvant Colorectal Cancer With Unresectable Liver MetastasesTreatment
NCT00320320Irinotecan Discontinuation and Reintroduction for Advanced Colorectal CancerTreatment
NCT00506168Study of Irinotecan & Capecitabine in Metastatic Colorectal CancerTreatment
NCT00889343Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal CancerTreatment